Moore DC, Soni AC, Hu B, Smith ET, et al. Rituximab, lenalidomide, and ibrutinib in relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type. Br J Haematol 2021 Oct 12. doi: 10.1111/bjh.17886.
PMID: 34642938